Damora Therapeutics Inc (DMRA)

NASDAQ · Biotechnology

31.74
+0.65 (+2.09%)
Updated Aug 18, 6:30 PM ET
AI Rating
Hold
Overall Score
55
Trend
75
Momentum
52
Risk
28

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 20, 2026 120 sessions Aug 14, 2026

AI Analysis

Damora Therapeutics Inc is trading at $31.74, up 2.09% on the session. The 50 day average sits at $26.81 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 57.7, which reads as strong, and MACD is bearish crossover. Volume is below average.

The nearest support is around $28.25 with resistance near $31.35, so that band frames the current range. Average daily movement is roughly $2.05, or about 6.4% of the share price, which is what any stop placement has to allow for. The overall health score of 55 out of 100 combines a trend score of 75, momentum of 52 and a risk score of 28.

Technical indicators

RSI (14)
57.7
strong
MACD
0.831
bearish crossover
SMA 20
30.20
SMA 50
26.81
SMA 200
--
unknown
ATR (14)
2.05
avg daily range
Support
28.25
Resistance
31.35
Volume vs 20d
0.64x
below average
Volatility
61.7%
annualised
1 month
+0.16%
3 months
+34.43%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.